Skip to content

VALOPHAR

Active
Private limited companyfounded 201213 yrs activeRue de la Croix-Rouge, Bos. 20, 5032 Gembloux, BelgiumKBO/BCE: BE 0508.535.267

VALOPHAR has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €263k and a net result of €31k. Equity is growing by ~40.7% per year across the filed fiscal years. Its solvency ranks better than 38% of 4157 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.9% (low).

Checked score

Score 2025
63 / 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability73▼-2
Solvency51▲+3
Growth78=
Track record100
Bankruptcy probability, 12 months
0.9% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €16k at 30 days acceptable
Liquidity ample (current ratio 1.68 against 1.64 in 2024; short-term debt: 23.7% and cash: 9.5% of total assets), but 74.2% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Eight signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies more bankruptcies →
raises risk · Multiple establishment units
Several establishment units mean more fixed costs, and such companies fail more often than a company with one establishment.
KBO · establishment units
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
25.8%
Return on assets
3%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 13 years 0 20 y
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
31 d late
2024
29 d late
2023
61 d late
2022
29 d late
2021
30 d late
2020
31 d late
2019
27 d late
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
23-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, full schema

Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€31k▼ 43.8%
2024 · €55k
2018: €-13k 2019: €-26k 2020: €36k 2021: €69k 2022: €50k 2023: €44k 2024: €55k
2018 → 2025
Working capital
€164k▲ 12.3%
2024 · €147k
2018: €-324k 2019: €-65k 2020: €-32k 2021: €43k 2022: €88k 2023: €106k 2024: €147k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€84k-€143k▲ 71.2%€180k▲ 25.7%€234k▲ 29.6%€263k▲ 12.5%
Operating result€99k-€91k▼ 8.4%€84k▼ 7.0%€95k▲ 12.4%€61k▼ 35.4%
Net result€69k-€50k▼ 27.0%€44k▼ 11.3%€55k▲ 23.6%€31k▼ 43.8%
Result per fiscal year
Operating resultNet result
€0€25k€50k€75k€100kOperating result 2021: €99k€99kNet result 2021: €69k€69kOperating result 2022: €91k€91kNet result 2022: €50k€50kOperating result 2023: €84k€84kNet result 2023: €44k€44kOperating result 2024: €95k€95kNet result 2024: €55k€55kOperating result 2025: €61k€61kNet result 2025: €31k€31k20212022202320242025
The operating result falls in 2025; 2025 is 35% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.02M
Fixed assets €613k▼ 6.7%
Current assets €406k▲ 7.7%
Equity and liabilities €1.02M
Equity €263k▲ 12.5%
Debt €756k▼ 5.5%
The debt ratio falls from 77.4% to 74.2%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€111k
2024 · €143k
Cash flow
€81k
2024 · €104k
Solvency
25.8%
2024 · 22.6%
Current ratio
1.68
2024 · 1.64
Quick ratio
0.98
2024 · 0.96
Debt / equity
2.88
2024 · 3.43
ROE
11.7%
2024 · 23.5%
ROA
3.0%
2024 · 5.3%
Interest coverage
6.61
2024 · 8.16
Debt
€756k
2024 · €800k
Debt ≤ 1 year
€242k
2024 · €231k
Debt > 1 year
€514k
2024 · €570k
Income taxes
€14k
2024 · €22k
Staff costs
€93k
2024 · €83k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€1.03M€1.02M
Fixed assets21/28€657k€613k
Tangible fixed assets22/27€657k€613k
Land and buildings22€526k€502k
Plant, machinery and equipment23€106k€93k
Furniture and vehicles24€25k€18k
Current assets29/58€377k€406k
Stocks and contracts in progress3€157k€169k
Stocks30/36€157k€169k
Amounts receivable within one year40/41€110k€137k
Trade receivables40€68k€82k
Other amounts receivable41€42k€54k
Cash at bank and in hand54/58€107k€97k
Deferred charges and accrued income490/1€3k€4k
Equity and liabilities
Total equity and liabilities10/49€1.03M€1.02M
Equity10/15€234k€263k
Contributions10/11€30k€30k=
Outside capital11€30k€30k=
Other1109/19€30k€30k=
Reserves13€202k€232k
Non-distributable reserves130/1€3k€3k=
Reserves not available under the articles1311€3k€3k=
Distributable reserves133€199k€229k
Profit (loss) carried forward14€2k€1k
Amounts payable17/49€800k€756k
Amounts payable after more than one year17€570k€514k
Financial debts170/4€570k€514k
Amounts payable within one year42/48€231k€242k
Current portion of amounts payable after more than one year42€61k€55k
Trade debts44€144k€157k
Suppliers440/4€144k€157k
Taxes, remuneration and social security45€24k€28k
Taxes450/3€5k€8k
Remuneration and social security454/9€19k€20k
Other amounts payable47/48€2k€2k=
Income statement Code20242025
Remuneration, social security and pensions62€83k€93k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€49k€50k
Other operating charges640/8€1€1
Gross operating margin9900€227k€205k
Operating profit (loss)9901€95k€61k
Financial charges65/66B€18k€17k
Recurring financial charges65€18k€17k
Profit (loss) for the period before taxes9903€77k€44k
Income taxes67/77€22k€14k
Profit (loss) for the period9904€55k€31k
Profit (loss) for the period to be appropriated9905€55k€31k
Appropriation of the result
Profit (loss) to be appropriated9906€58k€33k
Profit (loss) brought forward from the previous period14P€3k€2k
Transfer to equity691/2€54k€30k
To other reserves6921€54k€30k
Profit to be distributed694/7€2k€2k=
Return on contributions (dividend)694€2k€2k=
Social balance
Average headcount (FTE)90870.91.4

The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
31-08
NBB filing Annual accounts filed
fiscal year 2025 · full schema · 31 days late
2025
29-08
NBB filing Annual accounts filed
fiscal year 2024 · full schema · 29 days late
2024
31-12
Financial Equity above €200kEq €234k ▲29.6%
5 profitable years in a row build equity to €234k.
30-09
NBB filing Annual accounts filed
fiscal year 2023 · full schema · 61 days late
2023
31-12
Financial Equity above €150kEq €180k ▲25.7%
4 profitable years in a row build equity to €180k.
29-08
NBB filing Annual accounts filed
fiscal year 2022 · full schema · 29 days late
2022
31-12
Financial Equity above €100kEq €143k ▲71.2%
3 profitable years in a row build equity to €143k.
30-08
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 30 days late
2021
31-12
Financial Highest result since 2018net €69k ▲90.8%
Operating result €99k, net result €69k, both a record.
31-08
NBB filing Annual accounts filed
fiscal year 2020 · micro schema · 31 days late
2020
31-12
Financial Back to profitnet €36k
Net result €36k after 2 loss-making years.
27-08
NBB filing Annual accounts filed
fiscal year 2019 · micro schema · 27 days late
2019
31-12
Financial Weakest financial yearnet €-26k
Net result drops to €-26k, the lowest in the series; recovery starts the following year.
23-08
NBB filing Annual accounts filed
fiscal year 2018 · micro schema · 23 days late
2018
30-08
NBB filing Annual accounts filed
fiscal year 2017 · micro schema · 30 days late
2017
24-08
NBB filing Annual accounts filed
fiscal year 2016 · micro schema · 24 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Gembloux · 2 establishment units since 2013
establishment approximate All 2 establishment units on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Rue de la Croix-Rouge, Bos. 205032 Gembloux
Ground area
2,031 m²
Building footprint
178 m²
Volume, LiDAR
726 m³
2 parcels, Wallonia · tallest building 7.9 m, ±2 floors. Linked by address, not a title deed.
2 establishment units
Valophar sprl
Rue de la Croix-Rouge, Bos. 20, 5032 GemblouxRetail trade
since 20132.214.997.473
Pharmacie Brodéoux
Chaussée de Namur 390, 5030 GemblouxRetail sale of pharmaceutical products
since 20192.311.909.975
2 parcels
Wallonia 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
92011C0230/00A003 Wallonia 1,030 m² 1 · 58 m² -
92019C0274/00R000 Wallonia 1,001 m² 1 · 120 m² 7.9 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 3,527 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded18-12-2012
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 13 filingsAddress and cadastre registers

Data from official sources, last processed on 23-09-2026. Scores and ratios are computed by Checked and are not a credit decision.

Contact details

2 entries
E-mail:valophar@gmail.com
Establishment Gembloux 2.214.997.473
Phone:081/633997
Establishment Gembloux 2.214.997.473